Form 4: Charles River Laboratories CEO James C. Foster Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reports a transaction involving common stock on May 29, 2024.
Summary
- On May 29, 2024, James C. Foster, the Chairman, President, and CEO of Charles River Laboratories International, Inc., reported a transaction involving the company's common stock.
- The transaction involved the disposition of 1,274 shares at a price of $214.51.
- Following the transaction, Foster directly owns 223,044 shares of common stock.
- Foster also indirectly owns shares through various GRATs (Grantor Retained Annuity Trusts) and trusts, as well as shares held by his spouse.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is common for executives to have stock transactions as part of their compensation or personal financial management.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects an insider's activity, but the volume is relatively small compared to the overall shares outstanding.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of the reported transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.